| Literature DB >> 31285529 |
Camille Lemattre1, Marion Imbert-Bouteille1, Vincent Gatinois1, Paule Benit2, Elodie Sanchez1,3, Thomas Guignard1, Frédéric Tran Mau-Them1,4, Emmanuelle Haquet1, François Rivier5, Emilie Carme5, Agathe Roubertie5, Anne Boland6, Doris Lechner6, Vincent Meyer6, Julien Thevenon7, Yannis Duffourd4, Jean-Baptiste Rivière4, Jean-François Deleuze6, Constance Wells1, Florence Molinari8, Pierre Rustin2, Patricia Blanchet1, David Geneviève9,10.
Abstract
Early infantile epileptic encephalopathy (EIEE) is a heterogeneous group of severe forms of age-related developmental and epileptic encephalopathies with onset during the first weeks or months of life. The interictal electroencephalogram (EEG) shows a "suppression burst" (SB) pattern. The prognosis is usually poor and most children die within the first two years or survive with very severe intellectual disabilities. EIEE type 3 is caused by variants affecting function, in SLC25A22, which is also responsible for epilepsy of infancy with migrating focal seizures (EIMFS). We report a family with a less severe phenotype of EIEE type 3. We performed exome sequencing and identified two unreported variants in SLC25A22 in the compound heterozygous state: NM_024698.4: c.[813_814delTG];[818 G>A] (p.[Ala272Glnfs*144];[Arg273Lys]). Functional studies in cultured skin fibroblasts from a patient showed that glutamate oxidation was strongly defective, based on a literature review. We clustered the 18 published patients (including those from this family) into three groups according to the severity of the SLC25A22-related disorders. In an attempt to identify genotype-phenotype correlations, we compared the variants according to the location depending on the protein domains. We observed that patients with two variants located in helical transmembrane domains presented a severe phenotype, whereas patients with at least one variant outside helical transmembrane domains presented a milder phenotype. These data are suggestive of a continuum of disorders related to SLC25A22 that could be called SLC25A22-related disorders. This might be a first clue to enable geneticists to outline a prognosis based on genetic molecular data regarding the SLC25A22 gene.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31285529 PMCID: PMC6871179 DOI: 10.1038/s41431-019-0433-2
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246